WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Exit Postmarket & security

THE TAPE

MintNeuro raises 4.4 million euros for chips designed into neural implants iRhythm closes the VitalConnect deal at $287.5M, mostly in cash HeartSciences clears the MyoVista ECG hardware under K260005 without its AI algorithm FDA approves an Abbott update that shows CardioMEMS patients their own pressure readings UK accepts 44 AI commission recommendations and moves to continuous device monitoring Click Therapeutics clears Motivista for the negative symptoms of schizophrenia NeuWire Medical wins an IDE for a 135-patient trial of battery-free vagus nerve stimulation GE HealthCare pays $945M cash for Sofie Biosciences and 15 PET manufacturing sites Zenflow raises $52M and hands Cook Medical US distribution for the Spring implant MintNeuro raises 4.4 million euros for chips designed into neural implants iRhythm closes the VitalConnect deal at $287.5M, mostly in cash HeartSciences clears the MyoVista ECG hardware under K260005 without its AI algorithm FDA approves an Abbott update that shows CardioMEMS patients their own pressure readings UK accepts 44 AI commission recommendations and moves to continuous device monitoring Click Therapeutics clears Motivista for the negative symptoms of schizophrenia NeuWire Medical wins an IDE for a 135-patient trial of battery-free vagus nerve stimulation GE HealthCare pays $945M cash for Sofie Biosciences and 15 PET manufacturing sites Zenflow raises $52M and hands Cook Medical US distribution for the Spring implant

UK accepts 44 AI commission recommendations and moves to continuous device monitoring

MedDevice Startups Staff · 1 day ago · 2 min read · Via Fierce Biotech

The UK government accepted all 44 recommendations from the National Commission into the Regulation of AI in Healthcare on October 6. The change that matters: the MHRA moves from a single approval check to continuous monitoring of AI-based devices across their lifecycle.

An implementation roadmap arrives in spring 2027. The MHRA has also opened applications for Phase 3 of AI Airlock, its regulatory sandbox for AI-enabled devices, with the testing shaped by the Commission's recommendations. Health Innovation Minister James Frith said innovation must never come at the expense of patient safety, and called the work a continually evolving process.

If you are taking an AI device into the UK, the planning assumption changes. Post-market performance evidence stops being a periodic exercise and becomes a standing obligation, which means the monitoring pipeline has to be funded before first revenue.

Questions & Answers

What did the UK government accept on October 6, 2026?

The UK government accepted all 44 recommendations from the National Commission into the Regulation of AI in Healthcare. The main change is that the MHRA will monitor AI-based medical devices continuously across their lifecycle instead of checking them once at approval.

When will the MHRA publish its AI regulation implementation roadmap?

The MHRA implementation roadmap for the National Commission into the Regulation of AI in Healthcare recommendations is due in spring 2027.

Is the MHRA AI Airlock still open to applications?

Yes. Alongside the October 6, 2026 announcement, the MHRA opened applications for Phase 3 of AI Airlock, its regulatory sandbox for AI-enabled medical devices.

← Back to Regulatory